The Neuroscience of Being Human

The Neuroscience of Nitrous Oxide

How a gas that blocks NMDA receptors and releases endogenous opioids became the most accessible dissociative in the world, why it destroys vitamin B12 with every use, and what subacute combined degeneration reveals about the hidden cost of a legal high

1,540-word article with 8 Harvard references.

Triple mechanism: NMDA, opioid, and GABA

Nitrous oxide is pharmacologically unusual in acting through three distinct mechanisms simultaneously. Emmanouil and Quock (2007) reviewed the evidence for each. The primary mechanism is NMDA receptor antagonism. Like ketamine, nitrous oxide blocks the NMDA receptor channel, reducing glutamate-mediated excitatory neurotransmission. The dissociative quality of the nitrous oxide experience, the sense of detachment from body and environment, the distortion of sound and time, and the dreamlike perceptual alterations, reflects this NMDA blockade in cortical and limbic circuits. Ranft et al. (2006), using electrophysiological recordings, confirmed that nitrous oxide attenuates both pre- and postsynaptic NMDA receptor-mediated transmission, establishing the mechanism at the level of individual synapses.

The second mechanism is endogenous opioid release. Nitrous oxide stimulates the release of endorphins and enkephalins, producing the analgesic and mildly euphoric component of its effect. This is why nitrous oxide has been used as an analgesic in dentistry and obstetrics for more than a century: it provides genuine pain relief through the brain's own opioid system. The third mechanism is modulation of GABA-A receptor function, contributing anxiolytic and sedative effects. The combination of NMDA antagonism, opioid release, and GABAergic modulation from a single molecule explains why the nitrous oxide experience is qualitatively different from either pure dissociatives like ketamine or pure opioids like morphine. It borrows from both pharmacological worlds and adds its own distinctive character.

The B12 catastrophe: cobalt oxidation and methionine synthase

The most important thing about nitrous oxide that most recreational users do not know is that it destroys vitamin B12. The mechanism is chemical rather than pharmacological. Vitamin B12 contains a cobalt ion at its centre that must be in the Co(I) reduced state to function as a cofactor for the enzyme methionine synthase. Nitrous oxide irreversibly oxidises this cobalt ion to its Co(III) state, rendering the B12 molecule permanently inactive. The oxidation is not dose-dependent in the conventional pharmacological sense. Every exposure to nitrous oxide oxidises a proportion of the body's B12. A single recreational use in a person with adequate B12 stores may produce no measurable clinical effect. Repeated use, particularly in individuals with marginal or depleted B12 reserves, produces progressive functional B12 deficiency regardless of dietary B12 intake (Sanders et al., 2008).

Methionine synthase is not an obscure enzyme. It catalyses the conversion of homocysteine to methionine, which is then converted to S-adenosylmethionine, the universal methyl donor required for DNA methylation, protein methylation, and critically, the methylation reactions involved in myelin synthesis. When methionine synthase is inactivated, the methylation pathway stalls. Myelin, the insulating sheath that surrounds and protects nerve fibres throughout the central and peripheral nervous system, cannot be properly maintained. Savage and Ma (2014) reviewed the downstream consequences: demyelination of the dorsal columns of the spinal cord, demyelination of the corticospinal tracts, peripheral neuropathy, and megaloblastic anaemia from impaired DNA synthesis in rapidly dividing cells. The gas that produces thirty seconds of euphoria is dismantling the infrastructure that allows the nervous system to conduct signals.

Subacute combined degeneration: the neurological emergency

Thompson et al. (2015), writing in Practical Neurology, described the clinical presentation that emergency physicians and neurologists have encountered with increasing frequency as recreational nitrous oxide use has risen. Subacute combined degeneration of the spinal cord presents with sensory symptoms first: numbness and tingling in the hands and feet, often described as a glove-and-stocking distribution. As demyelination progresses, proprioception is impaired. The patient becomes unsteady on their feet, unable to detect the position of their limbs in space. Walking becomes difficult. Limb weakness develops as the corticospinal tracts are affected. In severe cases, the patient is unable to walk and may develop bladder dysfunction.

Cousaert et al. (2013) documented the MRI findings: hyperintense signal in the dorsal columns of the cervical and thoracic spinal cord, visible as bright lines running up the back of the cord on T2-weighted imaging. The pattern is characteristic and recognisable, but only if the clinician knows to look for it and to ask about nitrous oxide use. The condition is a medical emergency because the demyelination is progressive while B12 remains inactivated. Immediate high-dose intramuscular B12 supplementation can halt the progression and, if administered early enough, allow partial or complete recovery. Delay in diagnosis allows the damage to become irreversible. The tragedy is that many cases present late because neither the patient nor the initial treating physician connects the neurological symptoms with a gas that the patient considers harmless.

Prevalence, perception, and the gap between the two

Kaar et al. (2016), analysing data from the Global Drug Survey, documented that nitrous oxide is one of the most commonly used recreational substances worldwide, ranking consistently among the top ten in survey data from multiple countries. Use is concentrated among young adults aged eighteen to twenty-five, with university students and nightlife populations showing particularly high prevalence. The typical pattern of use involves brief, repeated inhalations from small pressurised canisters, the silver whippet cartridges that litter the pavements of most British cities, or from larger catering-sized cylinders that supply multiple doses.

van Amsterdam et al. (2015) assessed the risk profile of recreational nitrous oxide use in the Netherlands and documented the gap between perceived and actual risk. Users consistently rated nitrous oxide as among the safest recreational drugs, comparable to caffeine in perceived harm. The pharmacological evidence does not support this perception. The B12 inactivation mechanism means that risk is cumulative and partially invisible. A user may consume nitrous oxide dozens of times with no apparent ill effects, building a pattern of use based on the assumption of safety, while their functional B12 status progressively declines. The neurological consequences emerge when the cumulative B12 depletion crosses a threshold, and by the time symptoms appear, significant demyelination has already occurred. The perception of safety is not merely inaccurate. It is dangerous because it allows the pattern of use that produces harm to establish itself before any warning signal appears.

Other acute risks

Beyond the B12 mechanism, nitrous oxide carries additional acute risks that its recreational context amplifies. Inhalation from pressurised containers can cause cold burns to the lips, mouth, and airway from the rapid expansion of compressed gas. Hypoxia occurs when nitrous oxide is inhaled without adequate oxygen, particularly when users inhale from large cylinders using masks or bags that exclude ambient air. Loss of consciousness while standing produces falls and head injuries. Cases of pneumothorax and pneumomediastinum have been reported from pressurised gas delivery directly into the airway. The gas itself suppresses airway protective reflexes, meaning that a user who loses consciousness while inhaling is at risk of aspiration. These risks are entirely absent in the clinical context, where nitrous oxide is delivered as a controlled mixture with oxygen through calibrated equipment by trained personnel. They are present in the recreational context because the delivery system, a metal canister, a balloon, and a pavement, provides none of the safeguards that two centuries of anaesthetic practice have developed.